New nanoformulation provides a promising candidate for long-acting dosing of tenofovir Oct. 28, 2021 No Comments
Shionogi licenses S-365598 to ViiV for use in ultra long-acting HIV regimens Sep. 29, 2021 No Comments
Selective functional impairment of HIV-specific CD8+ T cells heralds aborted HIV control Sep. 28, 2021 No Comments
Pharmasyntez JSC identifies HIV-1 reverse transcriptase/ribonuclease H inhibitors Sep. 16, 2021 No Comments
RNA-directed gene therapy targeting shPromA/shCCR5 tested in chronic HIV infection model July 23, 2021 No Comments